Skip to main content
Aarti Pharmalabs Limited logo

Aarti Pharmalabs Limited — Investor Relations & Filings

Ticker · AARTIPHARM ISIN · INE0LRU01027 LEI · 335800TTAKRBNDK5P363 BSE.NS Manufacturing
Open in API
Filings indexed 246 across all filing types
Latest filing 2026-06-01 Call Transcript
Country IN India
Listing BSE.NS AARTIPHARM

About Aarti Pharmalabs Limited

https://www.aartipharmalabs.com/

Aarti Pharmalabs Limited is a manufacturer of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and xanthine derivatives. The company specializes in the development and production of complex chemistry-based products for the global pharmaceutical and generic drug industries. Its core portfolio includes APIs across diverse therapeutic areas such as oncology, cardiovascular, and anti-diabetics. Additionally, the company is a major producer of xanthines, including caffeine and theophylline. Aarti Pharmalabs offers comprehensive Contract Development and Manufacturing Organization (CDMO) services, leveraging its integrated research and development capabilities and large-scale manufacturing facilities. The organization maintains high regulatory standards, ensuring compliance with international quality benchmarks to serve a global clientele.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is a full text transcript of Aarti Pharmalabs Limited’s Q4 FY2026 earnings conference call, including management opening remarks and an analyst Q&A session. This matches the definition of a Call Transcript.
2026-06-01 English
Transcript of Q4 FY 26 Earnings Conference Call.
Call Transcript Classification · 95% confidence The document is the full text transcript of Aarti Pharmalabs’ Q4 FY2026 earnings conference call, including opening remarks, financial results overview, business segment details, and Q&A. This aligns exactly with a Call Transcript filing (CT).
2026-06-01 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 85% confidence The document is a compliance letter to stock exchanges under SEBI LODR Regulation 30/47 notifying that the company’s audited financial results for the quarter and year ended March 31, 2026 have been published in newspapers (Financial Express and Loksatta). It explicitly states “Newspaper Publication of Audited Financial Results” and encloses the press clipping rather than presenting a full standalone annual or quarterly report itself. This matches the definition of a Report Publication Announcement (RPA), which is used when a notice announces that a report has been published or is available.
2026-05-27 English
Newspaper Publication of Financial Results
Report Publication Announcement Classification · 80% confidence The document is a compliance letter sent by Aarti Pharmalabs to BSE and NSE under SEBI Listing Regulations announcing the newspaper publication of its standalone and consolidated audited financial results for the quarter and year ended March 31, 2026. It is not presenting a full annual or interim report itself, nor is it providing detailed financial statements in their official form; rather it states that the report has been published in newspapers (with copies enclosed). This matches the ‘Report Publication Announcement’ category (RPA).
2026-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 82% confidence The document is a formal notice to stock exchanges under SEBI LODR Regulation 30, informing about the uploading of the audio recording of the earnings conference call on the Company’s website. It does not contain actual financial data, earnings highlights, or the transcript itself, nor is it the earnings release. It is an announcement / regulatory disclosure to the exchange. It best fits the “Regulatory Filings” (RNS) category as a general regulatory announcement.
2026-05-26 English
Audio Recording of Conference Call for Investor and Analysts
Regulatory Filings Classification · 90% confidence The document is a brief regulatory announcement to stock exchanges under SEBI LODR Regulation 30, informing that the audio recording of the earnings conference call has been uploaded to the company’s website. It does not itself present earnings figures or detailed financials, nor is it the transcript. It is not the report itself but a compliance/intimation notice. This falls under General Regulatory Filings (RNS) as a miscellaneous regulatory announcement.
2026-05-26 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.